ClinicalTrials.gg
Not yet recruitingNCT07072767KT-CONNECTUpdated Oct 20, 2026

Technology-enabled Social Network Intervention to Increase Live Donor Kidney Transplantation

An interventional study of Digital education outreach intervention for kidney transplant access and human guide and Digital education outreach intervention for kidney transplant access only (unguided) in End-Stage Renal Disease, Chronic Kidney Diseases and Kidney Transplant, sponsored by State University of New York at Buffalo. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by State University of New York at Buffalo · Not applicable, Interventional, and Health services research

How we know

Updated Oct 20, 2026Start date movedPrimary completion moved+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
550
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 765 studies in Kidney Failure, Chronic with a site in United States — 65 open to participants now, 96 under way, 9 of them phase 3. Kidney Failure, Chronic · United States.

Planned enrollment
58th of 638
550 · median 48
Started
2027
with 3 others
No phase
287 of 765
28 open now
Primary completion
2030-10
later than 92 of 95 live
Registered
735th of 765
by date

Among the 765 studies in Kidney Failure, Chronic with a site in United States, this one is the 58th largest by planned enrollment of the 638 interventional ones that give a count, is one of 4 that started in 2027, is one of 287 with no phase, reaches primary completion later than 92 of the 95 other live ones, and was the 735th registered.

Kidney Failure, Chronic

2,115 studies on the registry are indexed under Kidney Failure, Chronic; 277 are open to participants now.

Browse Kidney Failure, Chronic studies →

Open to participants now

65 of the 765 studies in Kidney Failure, Chronic with a site in United States are open now. Recruiting first, the newest first:

60 more — sign in →

All 65 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 170 Kidney Failure, Chronic studies recruiting now, 109 (64%) set no upper age limit and 32 (19%) stop at 75 or younger; 18 take children under 18; 22 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 765 studies in Kidney Failure, Chronic with a site in United States, or all of them as a file.
02

Study summary

The study is a 2-arm randomized controlled trial among patients referred for kidney transplant evaluation at a single transplant center to compare the effects of a digital-analog intervention to increase living-donor kidney transplant access (KT-CONNECT) versus usual care. Following consent and baseline assessment, participants are randomized with equal allocation to 2 treatment arms: the KT-CONNECT intervention or Usual Care

Read the detailed description

Over a 3-year period the investigators will conduct a pilot 2-arm parallel randomized trial among patients referred for kidney transplantation at a single transplant center to compare the effects of the intervention over 6 months of intervention use and follow-up.

Participants will be recruited from a single transplant program in the US. Each week, electronic records will be accessed to identify patients and their carers who present for transplant evaluation at the transplant center for a kidney transplant, are aged 18 years and older, speak English, and are competent to provide informed consent . The investigators will exclude patients previously exposed to any component of the intervention, listed for transplantation at another center, and seeking multiorgan transplantation.

A stakeholder Advisory Council, whose members include patients and care partners, will review and provide ongoing feedback on the recruitment and retention plan. They will also provide input on assistive dissemination tools for organizations to engage individuals to use the resource.

Each potential participant will be invited to the study by a researcher who will describe the study and answer and questions, and provide a copy of the consent form describing study procedures and potential risks.

Those who sign electronic consent to participate will be asked to complete a baseline sociodemographic and pre-test survey. Upon completion, computer-generated randomization will stratify participants by self-reported race (Black versus Other), with equal allocation to 2 treatment arms: the intervention or usual care. Condition assignment of each participant will be concealed from transplant providers, but participants will become aware of their treatment assignment once they access the intervention.

KT-CONNECT is a digital-analog intervention with human support. It is based on animated video education targeted to patients, donors, and support persons, designed to address knowledge gaps, confidence , and lack of tools to pursue kidney transplantation and living donation that were identified in literature reviews, formative research, and video development studies as critical for optimal prospective kidney recipient and donor participation in LDKT. Other key components include (1) personalized donor outreach materials, (2) email reminders about study resources, and (3) practical assistance to ensure access to intervention, and (4) advise use the intervention and encourage outreach actions. All components of the intervention were developed through a user-centered design approach by involving kidney failure patients and social network members, to improve reach, usability and increase the likelihood of uptake.

In both intervention and control arms, the investigators chose 6 videos from the entire series to be delivered sequentially for a total duration of 13 minutes. The video content sets the stage for the intervention and introduces the viewer to an overview of LDKT, including addressing common misconceptions about live kidney donation, donor eligibility, donor evaluation, kidney paired donation, donation costs, and donor recovery. After completing the proscribed videos everyone then receives weekly emails with links to the full video curriculum centralized on a website and other local resources. Email messages introduce study videos and features and local resources that may interest users, provide access links, and encourage video viewing and sharing. Messages will be personalized with the participants name and provide researchers contact information. The videos on the website are activated for sharing through various modalities, including text, email, Facebook, and Twitter. The website also contains templates and examples for other donor outreach materials and practical engagement materials to promote awareness of the website. The website is open access from any electronic device. Finally, at clinic appointments participants will receive practical assistance to use intervention materials.

In the intervention arm, donor outreach will be supported by telephonic human guides who will provide tailored implementation support in 7 areas that include ensuring access, advising use, recommending features, encouraging donor outreach, and referrals to clinical services, support groups, community resources. Human guides will interact with participants over a 6-month period.

Control participants will not receive the intervention.

All participants routinely receive educational materials from non-study sources through usual Transplant Center protocols including written materials and clinical provider communications. Providers may recommend the study website or individuals may find it on their own.

After completing the proscribed video education, all participants will be invited to fill out serial surveys at 3 months post-evaluation. Participants will receive up to 6 reminders (5 automatic and 1 personalized) to complete surveys. At study conclusion, participants may be invited to an exit interview.

03

Conditions studied

  • End-Stage Renal Disease
  • Chronic Kidney Diseases
  • Kidney Transplant
  • Living Kidney Donor

Keywords

  • pilot randomized trial
  • behavioral intervention
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • referred to the transplant center for a kidney transplant
  • aged 18 years and older
  • speaks English

Exclusion criteria

Exclusion Criteria:

  • Previously exposed to any component of the intervention
  • Listed for a kidney transplant at another center (multilisted)
  • Seeking multiorgan transplantation
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
550 participants (estimated)

Study arms

  • Experimental
    KT-CONNECT

    KT-CONNECT is a multicomponent mobile education-outreach intervention to increase patient- and network-to-donor self-learning and outreach, about living donor kidney transplantation. Human guide support offered over a 6 month period to encourage use of the intervention and donor outreach.

    Behavioral: Digital education outreach intervention for kidney transplant access and human guide

  • Active comparator
    Usual Care

    Routine clinical support from non-study sources through usual Transplant Center protocols including clinic provider communications.

    Behavioral: Digital education outreach intervention for kidney transplant access only (unguided)

Interventions

  • BehavioralDigital education outreach intervention for kidney transplant access and human guide

    Receives (1) donor search materials, (2) electronic resource access messages, (3) practical assistance to use the intervention and empower taking the outreach action and (4) telephonic human guide

  • BehavioralDigital education outreach intervention for kidney transplant access only (unguided)

    Receives (1) donor search materials, (2) electronic resource access messages, and (3) practical assistance to use the intervention and empower taking the outreach action.

06

What researchers measure

Primary outcomes

  1. Living donor kidney transplant

    Count of living donor transplants at the transplant center on behalf of the study participants within 18 months from enrollment. The transplant episode is counted and added to a discrete field for all patients in the electronic medical record.

    Time frame: Baseline, post baseline 18 months

Secondary outcomes

  1. LDKT Perceived understanding

    Developed specifically for this study as a measure of perceived understanding about LDKT as delivered in the intervention condition. In this 4 item 4-point Likert questionnaire, total scores range from 3-16 with higher scores indicating greater LDKT-related understanding. The scale captures different dimensions of understanding including kidney transplant navigation, awareness of services, donor outreach.

    Time frame: Baseline, post baseline 3 months

  2. LDKT Conversational self-efficacy

    A 2-item survey testing confidence to communicate about LDKT with others. Items are rated on a scale of 1 to 4, total scores range from 2-8. Higher scores indicate greater confidence to communicate about LDKT with others.

    Time frame: Baseline, post baseline 3 months

  3. LDKT Beliefs scale

    Developed specifically for this study as a measure of patients' beliefs about LDKT. Questions were drawn from existing measures in the literature. We created a 2-item scale. One item captured the degree to which a person believes that LDKT is an advantage. The other item assessed the degree to which a person believes their social network is healthy enough to donate a kidney. Items are rated on a scale of 1 to 4. Total scores range from 2-8 with higher scores indicate greater concerns about live kidney donation.

    Time frame: Baseline, post baseline 3 months

  4. Donor outreach behaviors

    A measure of ongoing outreach toward living donor kidney transplantation. To assess LDKT action behaviors patients will be asked whether they had done any of 14 related behaviors adapted from existing measures in the literature. Patients who indicated they had done the action will be counted and scores will range from 0 to 14. Higher scores indicate more outreach.

    Time frame: Baseline, post baseline 3 months

  5. Living donor inquiry

    Count of living donor inquires to the transplant center on behalf of the study participants within 18 months from enrollment. Each inquiry (telephone call, email, letter) is counted and added to a discrete field for all patients in the electronic medical record.

    Time frame: Baseline, post-baseline at 18 months

  6. Living donor evaluation

    Count of living donor evaluations at the transplant center on behalf of the study participants within 18 months from enrollment. Each evaluation (at least one blood test or transplant provider consultation) is counted and added to a discrete field for all patients in the electronic medical record.

    Time frame: Baseline, post baseline at 18 months

Other outcomes

  1. Time to waiting-list placement

    The first time from evaluation to active placement on the kidney transplant waiting list will be assessed via medical record review.

    Time frame: 18 months

  2. Intervention Acceptability

    16-item survey assessing intervention usage, ease of use, and usefulness. Each question has 4 Likert-scale options bounded by strongly agree and strongly disagree or multiple responses specific to the question. Total scores range from 16-64 with higher scores indicate greater intervention acceptability.

    Time frame: Post-baseline 3 months

  3. Patient perception of donor offer

    A one item question asking participants if someone has agreed to donate a kidney to them, with the options of answering 'yes', 'no', or 'maybe'.

    Time frame: Baseline, post baseline 3 months

07

Study locations

1 site
  • Erie County Medical Center, 462 Grider Street
    Buffalo, New York 14215, United States
08

References and documents

Individual participant data

Plan to share: No — No funding available for sharing

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2027; primary completion for Oct 2030, 36 months later.

Of 349 non-industry interventional studies with no phase under Kidney Failure, Chronic, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 47. This study's planned 36 months is above that.

Counting every sponsor, half of 427 studies reached it within 22 months; a quarter within 8 and three quarters within 45.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 20, 2026: start Jan 2027 → Oct 2027, primary completion Jan 2030 → Oct 2030 and completion Jul 2030 → Oct 2030.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 31, 2025
First posted
Jul 18, 2025
StartEst.
Oct 1, 2027was Jan 2027
Primary completionEst.
Oct 1, 2030was Jan 2030
CompletionEst.
Oct 1, 2030was Jul 2030
Last update
Oct 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Jan 1, 2027→Oct 1, 2027
Oct 20, 2026
Primary completion
Jan 1, 2030→Oct 1, 2030
Oct 20, 2026
Study completion
Jul 1, 2030→Oct 1, 2030
Oct 20, 2026
Enrollment
430→550
Oct 20, 2026
Interventions
Arms added: KT-CONNECT·Usual Care; arms removed: KidneyTime-2 with human support·KidneyTime-2 without human support
Oct 20, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedLiving donor inquirykidney transplantTime frame: Baseline, post baseline 6 months → Baseline, post baseline 18 months
Oct 20, 2026
Secondary outcomes
7 time frame changed, 2 added, 1 description edited
What changed in the outcomes
  • AddedLiving donor inquiryTime frame: Baseline, post-baseline at 18 months
  • AddedLiving donor evaluationTime frame: Baseline, post baseline at 18 months
  • Time frameLDKT Perceived understandingBaseline, post baseline 6 months → Baseline, post baseline 3 months
  • Time frameLDKT Conversational self-efficacyBaseline, post baseline 6 months → Baseline, post baseline 3 months
  • Time frameLDKT Beliefs scaleBaseline, post baseline 6 months → Baseline, post baseline 3 months
  • Time frameDonor outreach behaviorsBaseline, post baseline 6 months → Baseline, post baseline 3 months
  • DescriptionLDKT Perceived understanding: how it is measured was reworded
  • Time frameother outcomeTime to waiting-list placement12 months → 18 months
  • Time frameother outcomeIntervention AcceptabilityPost-baseline 6 months → Post-baseline 3 months
  • Time frameother outcomePatient perception of donor offerBaseline, post baseline 6 months → Baseline, post baseline 3 months
Oct 20, 2026
Title
Hybrid Dissemination Study of A Digital-AnalogTechnology-enabled Social Network Intervention to Increase Live Donor Kidney Transplantation
Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    Start date Jan 1, 2027→Oct 1, 2027
    Primary completion Jan 1, 2030→Oct 1, 2030
    Study completion Jul 1, 2030→Oct 1, 2030
    Enrollment 430→550
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedLiving donor inquirykidney transplantTime frame: Baseline, post baseline 6 months → Baseline, post baseline 18 months
    Secondary outcomes 7 time frame changed, 2 added, 1 description edited
    What changed in the outcomes
    • AddedLiving donor inquiryTime frame: Baseline, post-baseline at 18 months
    • AddedLiving donor evaluationTime frame: Baseline, post baseline at 18 months
    • Time frameLDKT Perceived understandingBaseline, post baseline 6 months → Baseline, post baseline 3 months
    • Time frameLDKT Conversational self-efficacyBaseline, post baseline 6 months → Baseline, post baseline 3 months
    • Time frameLDKT Beliefs scaleBaseline, post baseline 6 months → Baseline, post baseline 3 months
    • Time frameDonor outreach behaviorsBaseline, post baseline 6 months → Baseline, post baseline 3 months
    • DescriptionLDKT Perceived understanding: how it is measured was reworded
    • Time frameother outcomeTime to waiting-list placement12 months → 18 months
    • Time frameother outcomeIntervention AcceptabilityPost-baseline 6 months → Post-baseline 3 months
    • Time frameother outcomePatient perception of donor offerBaseline, post baseline 6 months → Baseline, post baseline 3 months
    Interventions Arms added: KT-CONNECT·Usual Care; arms removed: KidneyTime-2 with human support·KidneyTime-2 without human support
    Title Hybrid Dissemination Study of A Digital-AnalogTechnology-enabled Social Network Intervention to Increase Live Donor Kidney Transplantation
    + 2 other changes: verification date and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07072767
Responsible party
Liise Kayler (Principal Investigator, State University of New York at Buffalo) — Principal investigator
First posted
Jul 18, 2025
Start date
Oct 1, 2027 (estimated)
Primary completion
Oct 1, 2030 (estimated)
Completion
Oct 1, 2030 (estimated)
Last update
Oct 20, 2026

Study contacts

Liise Kayler, MD, MS, FACS
Contact
lkayler@ecmc.edu
716-898-3318

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion